









Markets
/
Stocks
/
nasdaq-om
/

Outset Medical Inc

14.170USD

+0.240+1.72%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

251.74MMarket Cap

LossP/E TTM



Outset Medical Inc

14.170

+0.240+1.72%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

112 / 207

Overall Ranking

286 / 4723

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Buy

Current Rating

25.750

Target Price

+85.92%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Overvalued

The company’s latest PE is -0.36, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 16.26M shares, increasing 42.42% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 991.43K shares of this stock.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 6.62, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 31.42M, representing a year-over-year increase of 14.72%, while its net profit experienced a year-over-year increase of 46.19%.

Score

Industry at a Glance

Previous score

6.62

Change



Financials

6.35

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.70

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

6.95

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.02

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.10

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -0.36, which is 1267.77% below the recent high of -4.88 and -16620.39% above the recent low of -59.61.

Score

Industry at a Glance

Previous score

2.00

Change

-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 112/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 8.50, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Outset Medical Inc is 23.50, with a high of 39.00 and a low of 17.00.

Score

Industry at a Glance

Previous score

8.50

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Buy

Current Rating

25.750

Target Price

+84.85%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Outset Medical Inc

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 2.25, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 14.57 and the support level at 13.15, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.22

Change

0.03

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.273

Neutral

RSI(14)

47.480

Neutral

STOCH(KDJ)(9,3,3)

57.743

Neutral

ATR(14)

0.652

High Vlolatility

CCI(14)

61.582

Neutral

Williams %R

35.211

Buy

TRIX(12,20)

-0.224

Sell

StochRSI(14)

66.292

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

13.868

Buy

MA10

13.824

Buy

MA20

13.829

Buy

MA50

15.253

Sell

MA100

16.531

Sell

MA200

14.691

Sell

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 91.74%, representing a quarter-over-quarter increase of 8.89%. The largest institutional shareholder is The Vanguard, holding a total of 991.43K shares, representing 5.58% of shares outstanding, with 13.25% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

2.58M

+1040.39%

PFM Health Sciences, LP

1.69M

Durable Capital Partners LP

1.74M

T. Rowe Price Investment Management, Inc.

1.60M

+659.32%

Alyeska Investment Group, L.P.

1.70M

Woodline Partners LP

1.33M

The Vanguard Group, Inc.

Star Investors

173.32K

-0.35%

Perceptive Advisors LLC

833.33K

MFS Investment Management

840.25K

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 3.16, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 2.13. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.